← Back to all trials
Not Yet Recruiting
NCT07611786
Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia
Sex: All
Ages: 16 Years – N/A
Healthy volunteers: Yes
Enrollment: 40
Sponsor: University of Alabama at Birmingham
Location: University of Alabama at Birmingham Birmingham Alabama
Summary
The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, and health-related quality of life as participants transition from pediatric to adult healthcare services.
Eligibility Criteria
Inclusion Criteria:
YA Participants
* Diagnosis of congenital adrenal hyperplasia (any subtype or severity)
* Age ≥16 years
* Active follow-up within the pediatric endocrinology clinic
* English-speaking
* Cognitively able to complete questionnaires with or without assistance
* Anticipated ability to participate in CAH-T visits during the study period Caregiver Participants
* Parent, guardian, or primary support person of an enrolled AYA participant Provider Participants
* Pediatric endocrinologists, nurse practitioners, or transition-related clinical staff involved in CAH care for at least 6 months
Exclusion Criteria:
* Significant cognitive impairment precluding participation
* Inability to complete study procedures
* Inability to provide informed consent/assent
Source: ClinicalTrials.gov (NCT07611786). StuddyBuddy aggregates publicly available trial information.